Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DISHMAN CARBOGEN AMCIS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DISHMAN CARBOGEN AMCIS ALKEM LABORATORIES/
DISHMAN CARBOGEN AMCIS
 
P/E (TTM) x 30.7 -20.5 - View Chart
P/BV x 6.4 0.6 1,017.8% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   DISHMAN CARBOGEN AMCIS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-24
DISHMAN CARBOGEN AMCIS
Mar-24
ALKEM LABORATORIES/
DISHMAN CARBOGEN AMCIS
5-Yr Chart
Click to enlarge
High Rs5,519283 1,950.6%   
Low Rs3,211113 2,835.4%   
Sales per share (Unadj.) Rs1,059.4166.8 635.0%  
Earnings per share (Unadj.) Rs151.5-9.8 -1,547.9%  
Cash flow per share (Unadj.) Rs176.510.0 1,758.2%  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs860.8358.9 239.8%  
Shares outstanding (eoy) m119.57156.78 76.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.11.2 347.0%   
Avg P/E ratio x28.8-20.2 -142.3%  
P/CF ratio (eoy) x24.719.7 125.3%  
Price / Book Value ratio x5.10.6 918.8%  
Dividend payout %26.40-   
Avg Mkt Cap Rs m521,91031,059 1,680.4%   
No. of employees `000NANA-   
Total wages/salary Rs m22,01012,082 182.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m126,67626,158 484.3%  
Other income Rs m3,108508 612.0%   
Total revenues Rs m129,78426,666 486.7%   
Gross profit Rs m21,2402,578 824.0%  
Depreciation Rs m2,9933,109 96.3%   
Interest Rs m1,1241,200 93.7%   
Profit before tax Rs m20,231-1,223 -1,654.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,117312 678.6%   
Profit after tax Rs m18,115-1,535 -1,180.5%  
Gross profit margin %16.89.9 170.1%  
Effective tax rate %10.5-25.5 -41.0%   
Net profit margin %14.3-5.9 -243.8%  
BALANCE SHEET DATA
Current assets Rs m104,11619,282 540.0%   
Current liabilities Rs m39,94625,547 156.4%   
Net working cap to sales %50.7-24.0 -211.5%  
Current ratio x2.60.8 345.3%  
Inventory Days Days2241 53.5%  
Debtors Days Days656 1,008.8%  
Net fixed assets Rs m36,48576,424 47.7%   
Share capital Rs m239314 76.2%   
"Free" reserves Rs m102,68655,961 183.5%   
Net worth Rs m102,92556,275 182.9%   
Long term debt Rs m4002,456 16.3%   
Total assets Rs m140,60195,706 146.9%  
Interest coverage x19.00 -99,526.8%   
Debt to equity ratio x00 8.9%  
Sales to assets ratio x0.90.3 329.6%   
Return on assets %13.7-0.3 -3,911.5%  
Return on equity %17.6-2.7 -645.4%  
Return on capital %20.70 -53,007.1%  
Exports to sales %16.00-   
Imports to sales %00-   
Exports (fob) Rs m20,316NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m20,3163,187 637.5%   
Fx outflow Rs m5,413327 1,657.3%   
Net fx Rs m14,9032,860 521.1%   
CASH FLOW
From Operations Rs m19,4813,840 507.3%  
From Investments Rs m-10,085-2,295 439.4%  
From Financial Activity Rs m-11,450-222 5,169.3%  
Net Cashflow Rs m-2,0751,323 -156.8%  

Share Holding

Indian Promoters % 55.7 59.3 93.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 28.2 9.4 300.6%  
FIIs % 9.0 8.2 110.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 44.3 40.7 109.0%  
Shareholders   74,744 55,280 135.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs DISHMAN CARBOGEN AMCIS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs DISHMAN CARBOGEN AMCIS Share Price Performance

Period ALKEM LABORATORIES DISHMAN CARBOGEN AMCIS S&P BSE HEALTHCARE
1-Day -1.08% 4.08% 0.92%
1-Month -9.18% 28.86% -0.55%
1-Year 22.28% 30.75% 43.17%
3-Year CAGR 19.04% 0.95% 20.23%
5-Year CAGR 21.67% 13.02% 26.16%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the DISHMAN CARBOGEN AMCIS share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 55.7% stake in the company. In case of DISHMAN CARBOGEN AMCIS the stake stands at 59.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of DISHMAN CARBOGEN AMCIS.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 26.4%.

DISHMAN CARBOGEN AMCIS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of DISHMAN CARBOGEN AMCIS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.